I did an interview today with Dagbladet (Norwegian Newspaper), which will be doing a bit on the petition I did for wanted methodological changes...
My life is complete I have finally seen Jonathan go absolutely livid in full CAPS LOCK :woot:
@MSEsperanza Yes ur right in the publication its strongly suggested he means music has an effect on ME in the conclusion: "the increased recovery...
"Smearing campaigns doesn't strengthen the patients' interest" It certainly does :laugh: The participants had lower reported activity at study...
"The "specific antibodies" we know of in Cfs, and you can ask Prof. Edwards he will agree with me, are found in many other diseases as side...
"A proportion had steps increased after trial - but in ritixumab a similar proportion also seemed to have been helped, which was then shown to be...
"The autoimmune part of Cfs is a beaten dead horse to me" - To you maybe, but we have barely scratched the surface with trying rituximab and...
Im surprised theres been so little talk about this publication, 9 people went back to studies/work, and then the rest of the responders might or...
It would be cheaper for her to talk to a good friend Same effect
Its kind of bizarre, many of the so called "cured" in the recovery groups that get advertised left and right, are not actually recovered but are...
I mean, ill take ur word for it Jonathan, but when reading up on it before trying it, what made me decide to go for it was the very low death rate...
It is for sure not higher than 5 perc with CCC, im not gonna bother having a technical argument about this sorry.
Rituximab is a very safe drug taken in isolation (not with other immunosuppressives), contrary to what many claim here. All the serious adverse...
I dont know how u can reach the conclusion that "They were mildly improved at best" after reading this study I mean look at the graphs...
Yes 5 percent has been the mean in the studies looked at (not after strict criteria,), the systematic review being one of them. Im not claiming it...
We dont know what the placebo rate will be next time though, it seemed unusually high for me
I dont disagree that we have to look at the results with great caution, but I dont think it is very likely that the study had so many patients...
5): Multicenter phase 3!
"Although the double blinded RituxME trial showed no significant differences between the rituximab and placebo groups for the outcome measures...
"Also of note, three of the patients who registered relapse at 3–4 years still reported a 2-fold increase of their percent function levels as...
Separate names with a comma.
